Companion Animal Pharmaceuticals Market Intelligence Report - Global Forecast to 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Companion Animal Pharmaceuticals Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Companion Animal Pharmaceuticals Market is projected to reach USD 21,304.88 million by 2027 from USD 12,297.83 million in 2021, at a CAGR 9.59% during the forecast period.

In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Companion Animal Pharmaceuticals Market size was estimated at USD 4,084.14 million in 2021 and expected to reach USD 4,408.13 million in 2022, at a CAGR 9.09% to reach USD 6,886.82 million by 2027.
• The Asia-Pacific Companion Animal Pharmaceuticals Market size was estimated at USD 3,834.30 million in 2021 and expected to reach USD 4,296.20 million in 2022, at a CAGR 10.43% to reach USD 6,957.22 million by 2027.
• The Europe, Middle East & Africa Companion Animal Pharmaceuticals Market size was estimated at USD 4,379.38 million in 2021 and expected to reach USD 4,751.22 million in 2022, at a CAGR 9.28% to reach USD 7,460.84 million by 2027.

Market Segmentation & Coverage:

The report on companion animal pharmaceuticals identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making.

This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

Company Usability Profiles:

• Ashish Life Science Pvt. Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Chanelle Pharma
• Dechra Pharmaceuticals PLC
• Eco Animal Health Group PLC
• Elanco Animal Health Incorporated
• Endovac Animal Health, LLC
• Hipra Laboratories, S.A.
• Indian Immunologicals Ltd.
• Inovet Group
• Kyoritsu Seiyaku Corporation
• Lutim Pharma Pvt. Ltd.
• Merck & Co. Inc.
• Norbrook Laboratories Ltd.
• Tianjin Ringpu Biotechnology Co., Ltd.
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis Inc.

Scope of the Report

Indication:

• Behavioral Disorders
• Dermatologic Diseases
• Infectious Diseases
• Orthopedic Diseases
• Pain

Animal Type:

• Cats
• Dogs
• Horses

Distribution Channel:

• Retail Pharmacies
• Veterinary Clinics
• Veterinary Hospitals

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • Alabama
    • Alaska
    • California
    • Florida
    • Georgia
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • South Carolina
    • Texas
    • Virginia
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

For more information about this report visit https://www.researchandmarkets.com/r/oshl5t